"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
| Descriptor ID |
D001943
|
| MeSH Number(s) |
C04.588.180 C17.800.090.500
|
| Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1997 | 3 | 1 | 4 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 3 | 1 | 4 |
| 2002 | 7 | 1 | 8 |
| 2003 | 12 | 1 | 13 |
| 2004 | 8 | 4 | 12 |
| 2005 | 5 | 1 | 6 |
| 2006 | 10 | 0 | 10 |
| 2007 | 9 | 0 | 9 |
| 2008 | 7 | 1 | 8 |
| 2009 | 14 | 1 | 15 |
| 2010 | 16 | 7 | 23 |
| 2011 | 12 | 2 | 14 |
| 2012 | 8 | 1 | 9 |
| 2013 | 7 | 6 | 13 |
| 2014 | 12 | 3 | 15 |
| 2015 | 15 | 1 | 16 |
| 2016 | 15 | 2 | 17 |
| 2017 | 15 | 0 | 15 |
| 2018 | 20 | 1 | 21 |
| 2019 | 17 | 2 | 19 |
| 2020 | 21 | 1 | 22 |
| 2021 | 20 | 1 | 21 |
| 2022 | 17 | 0 | 17 |
| 2023 | 10 | 0 | 10 |
| 2024 | 11 | 2 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells. Cancer Lett. 2024 Nov 01; 604:217267.
-
NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms. J Sex Med. 2024 08 01; 21(8):709-715.
-
Sustained delivery of celecoxib from nanoparticles embedded in hydrogel injected into the biopsy cavity to prevent biopsy-induced breast cancer metastasis. Breast Cancer Res Treat. 2024 Nov; 208(1):165-177.
-
Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1. J Pharmacol Exp Ther. 2024 Jun 21; 390(1):65-77.
-
Association Between COVID-19 and Planned and Postponed Cancer Screenings Among American Indian Adults Residing in California and Oklahoma, March-December 2020. Public Health Rep. 2025 Jan-Feb; 140(1):57-66.
-
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ? 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. J Clin Oncol. 2024 Sep 01; 42(25):3012-3021.
-
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy: A First-in-Human Randomized Pilot Study. Neuromodulation in Cancer Study (NCAN). Am J Clin Oncol. 2024 Sep 01; 47(9):425-430.
-
Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative. Cancer. 2024 Sep 15; 130(18):3147-3156.
-
Primary Human Breast Cancer-Associated Endothelial Cells Favor Interactions with Nanomedicines. Adv Mater. 2024 Jul; 36(28):e2403986.